Nexalin Technology, Inc.NXLNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR-89.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-89.5%/yr
Quarterly compound
Percentile
P64
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 0.33% |
| Q2 2025 | -44.43% |
| Q1 2025 | -44.90% |
| Q4 2024 | 312.93% |
| Q3 2024 | 5.40% |
| Q2 2024 | 60.32% |
| Q1 2024 | 32.65% |
| Q4 2023 | -95.14% |
| Q3 2023 | 1022.27% |
| Q2 2023 | 121.77% |
| Q1 2023 | -81.52% |
| Q4 2022 | 213.58% |
| Q3 2022 | 284.62% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | -100.00% |
| Q3 2021 | -57.07% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |